/5
0 avis
Very Long Term Follow up a Phase II Study of Post-Remission Subcutaneous (SC) Azacitidine (AZA) in Patients with AML Post-MDS or Higher-Risk (HR) MDS
Archive ouverte
Edité par CCSD ; American Society of Hematology -
International audience
Consulter en ligne
Chargement des enrichissements...